Syndax Pharmaceuticals Appoints Aaron A. Ondrey as Chief Financial Officer
Position
Chief Financial Officer
Company
Syndax Pharmaceuticals
New YorkBiotechnologyHealthcarePharmaceuticalBiopharmaDescription
Syndax Pharmaceuticals announces the appointment of Aaron A. Ondrey as Chief Financial Officer, effective November 9, 2026. Aaron brings over 25 years of experience in financial leadership within the biotechnology industry.
Quick answer
Syndax Pharmaceuticals Appoints Aaron A. Ondrey as Chief Financial Officer (November 2, 2026). Syndax Pharmaceuticals is based in New York, New York, United States.
- Who is the new Chief Financial Officer at Syndax Pharmaceuticals?
- Syndax Pharmaceuticals named Aaron A. Ondrey Chief Financial Officer, announced November 2, 2026.
- What did Syndax Pharmaceuticals announce on November 2, 2026?
- Syndax Pharmaceuticals announces the appointment of Aaron A. Ondrey as Chief Financial Officer, effective November 9, 2026. Aaron brings over 25 years of experience in financial leadership within the biotechnology industry.
- Where did Aaron A. Ondrey work before joining Syndax Pharmaceuticals?
- Aaron A. Ondrey joins from Beren Therapeutics.
- What does Syndax Pharmaceuticals do?
- Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies.
- Where is Syndax Pharmaceuticals based?
- Syndax Pharmaceuticals is based in New York, New York, United States.
- Which similar companies made leadership changes around the same time?
- AbbVie Inc. (November 2, 2026), Retension Pharmaceuticals (October 23, 2026), Kiniksa Pharmaceuticals, Ltd. (October 22, 2026) and Os Therapies (October 1, 2026) also announced leadership changes within 45 days of Syndax Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- AbbVie Director Resigns Following CEO Appointment at Align Technology (November 2, 2026)
- Retension Pharmaceuticals Appoints Robert Wong as Chief Accounting Officer (October 23, 2026)
- Kiniksa Pharmaceuticals Appoints Ross Moat as President and COO (October 22, 2026)
- OS Therapies Appoints Mr. Clem as Chief Commercial Officer and Mr. Knuettel as Chief Financial Officer (October 1, 2026)
- Richard J. Daly Appointed as Director of Aquestive Therapeutics (September 29, 2026)
- Menassie Taddese Appointed as Director at Xeris Biopharma (November 2, 2026)
Who to call at Syndax Pharmaceuticals, and when
A new leader at Syndax Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Syndax Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Syndax Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Syndax Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Syndax Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Syndax Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.